Question 1

How many shares of PTGX does JACOBS LEVY EQUITY MANAGEMENT, INC own?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of PTGX (PROTAGONIST THERAPEUTICS INC) before exiting the position in 2025-Q2.

Question 2

What is JACOBS LEVY EQUITY MANAGEMENT, INC's PTGX position worth?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC's PTGX position was last reported at $0 in 2025-Q2 before the exit.

Question 3

Is JACOBS LEVY EQUITY MANAGEMENT, INC buying or selling PTGX?

Accepted Answer

In 2025-Q2, JACOBS LEVY EQUITY MANAGEMENT, INC exited their PTGX position entirely (-100.0% change in shares).

Question 4

When did JACOBS LEVY EQUITY MANAGEMENT, INC first buy PTGX?

Accepted Answer

Based on available 13F filings, JACOBS LEVY EQUITY MANAGEMENT, INC first reported a position in PTGX in 2024-Q3. They have held the position across 20 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$55.69
2025-Q1	Unchanged	128,654	0.0%	$6.2M	0.0%	$48.88
2024-Q4	Unchanged	128,654	0.0%	$5M	0.0%	$38.51
2024-Q3	Decreased	128,654	-0.3%	$5.8M	0.0%	$44.56